Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Independent pharmacies generally offer lower prices for certain generic urologic medications than chain pharmacies.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Epigenetic differences affect hair loss in identical Japanese male twins.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Taking Saw palmetto and Pygeum africana can change the levels of certain steroids in urine, which could cause confusion in doping tests.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

AI improves biomaterial design by making it faster, cheaper, and more effective for personalized medicine.

Arab hair is generally thicker but less dense compared to other ethnicities, affecting hair disorder diagnosis and treatment.

Topical glucocorticoids thin the skin and change collagen structure.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

Alternative therapies for men's health lack strong scientific support and need more research.

GLP-1RA therapy may increase the risk of hair loss.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.

Survivors of severe COVID-19 need ongoing care to manage lasting health issues.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Mintop serum effectively reduces hair fall and promotes new growth safely.